Naoto T Ueno, MD, PhD· @teamoncology · X·· 2026-04-18Score60
Body
Our group will present the CD44v9-targeted antibody-drug conjugate as a novel therapy for advanced breast cancer at #AACR26
Heat 6 · 6 likes · 0 replies · 0 reposts
Source: Naoto T Ueno, MD, PhD · x.com